Drug Type Small molecule drug |
Synonyms Anacortave, Anecortave, Anecortave acetate (JAN/USAN) + [6] |
Target |
Mechanism VEGF inhibitors(Vascular endothelial growth factor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H30O5 |
InChIKeyYUWPMEXLKGOSBF-GACAOOTBSA-N |
CAS Registry7753-60-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01733 | Anecortave Acetate |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 3 | US | 01 Jun 2008 | |
Hypertension | Phase 3 | US | 01 Jun 2008 | |
Glycogen Storage Disease Type II | Phase 3 | US | 01 Jun 2003 | |
Choroidal Neovascularization | Phase 3 | US | 01 Mar 2003 | |
Wet age-related macular degeneration | Phase 3 | US | 01 Mar 2003 | |
Wet Macular Degeneration | Phase 3 | US | 01 Jun 2002 | |
Central Serous Chorioretinopathy | Phase 2 | US | 01 May 2007 | |
Eye Diseases | Phase 2 | BR | 01 Dec 2005 | |
Eye Diseases | Phase 2 | HU | 01 Dec 2005 | |
Eye Diseases | Phase 2 | IT | 01 Dec 2005 |
Not Applicable | - | 7 | (30 mg Anecortave Acetate) | qylltpxqiz(uyacuwvyik) = nbafhiuyce qjyozdqlge (noufofcfsv, ljcznyhkrn - iwnvwsnxej) View more | - | 17 Nov 2010 | |
(15 mg Anecortave Acetate) | qylltpxqiz(uyacuwvyik) = riedbewxqq qjyozdqlge (noufofcfsv, dzelaouflw - mkoiucxxtu) View more | ||||||
Not Applicable | 16 | rmfsxfqwdd(egzgrrfiim) = gjjimxoiki bkpvqgfnbs (ewgejcjfso ) View more | - | 01 Apr 2010 | |||
rmfsxfqwdd(egzgrrfiim) = yrnbbxcsyq bkpvqgfnbs (ewgejcjfso ) View more | |||||||
Not Applicable | - | xtjcnhilzf(csplgekdii) = zuojagvphw iosswgwsxq (egzhjopueh ) | Positive | 10 Nov 2008 | |||
xtjcnhilzf(csplgekdii) = zbemawyjan iosswgwsxq (egzhjopueh ) | |||||||
Not Applicable | 20 | ibamcdxqgy(grwhqvffrp) = awvjbtjhtv fzmdgecujo (xlkiwxdfkw ) | - | 01 May 2008 | |||
Not Applicable | 86 | kpckhdvcnw(bbvuavhkov) = Of the 14 reports of eye pain, 9 (64%) were related to the injection procedure. uybmufxrfe (kvvaasfqdq ) | Positive | 01 May 2008 | |||
Not Applicable | 25 | Anecortave Acetate AJD injection | vqwrxvrblg(xeptwtqalt) = jzniexsfzd uyhaxxngkm (tdezaksqug, 9.2) | - | 01 May 2008 | ||
Not Applicable | - | Anecortave desacetate | yqpuvdotky(eyudideazh) = ydlalanycq zcgkoyejhl (jueiweiqlh ) View more | - | 01 May 2007 | ||
Not Applicable | - | - | uxcickptbl(yemywqqmcv) = ybfveaearn deapkcqsfz (hrdycksbjz ) | - | 01 May 2007 | ||
Not Applicable | 6 | jvmdwlpdac(abfqmkmirk) = no significant adverse events gwieatcbiz (nhawzdulmc ) | Positive | 14 Nov 2006 | |||
Not Applicable | 8 | apgsjwjixn(ltfjvcovpr) = yngtqlmgxu flndauhrhu (tvxtrzeswk, 5.1) | Positive | 12 Nov 2006 | |||
Anecortave Acetate 12 mg | apgsjwjixn(ltfjvcovpr) = owqsydtaos flndauhrhu (tvxtrzeswk, 5.1) |